Cleared Traditional

K222683 - Fibroid Mapping Reviewer Application (FMRA) (FDA 510(k) Clearance)

Jul 2023
Decision
314d
Days
Class 2
Risk

K222683 is an FDA 510(k) clearance for the Fibroid Mapping Reviewer Application (FMRA). This device is classified as a System, Image Processing, Radiological (Class II - Special Controls, product code LLZ).

Submitted by Nesa Medtech Private Limited (Bengaluru, IN). The FDA issued a Cleared decision on July 17, 2023, 314 days after receiving the submission on September 6, 2022.

This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.2050.

Submission Details

510(k) Number K222683 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 06, 2022
Decision Date July 17, 2023
Days to Decision 314 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF

Device Classification

Product Code LLZ - System, Image Processing, Radiological
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.2050